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OVARIAN tumours in the mouse can be induced by different experimental
procedures (reviewed by Clifton, 1959). Howell, Marchant and Orr (1954) and
Biancifiori, Bonser and Caschera (1961) reported that a high incidence of ovarian
granulosa cell tumours appeared in mice following repeated cutaneous application
or oral administration of 7,12-dimethylbenz(a) anthracene (DMBA). Recently,
Jull, Streeter and Sutherland (1966) and Kuwahara (1967) noted that a single
application of DMBA by oral and intraveneous routes is effective in inducing
ovarian tumours in young adult mice. It is now well known that DMBA is a very
potent carcinogen capable of eliciting various types of neoplasms in mice, given
as newborns (Kelly and O'Gara, 1961; Roe, Rowson and Salaman, 1961; Toth,
Rappaport and Shubik, 1963). Thymic leukaemia is the tumour that appears
most frequently in younger ages in Swiss mice neonatally treated with DMBA.
Thus, it is possible to postulate that if the appearance of leukaemia could be
prevented, other types of tumours might appear in fairly high frequency in the
DMBA-exposed Swiss mice. Thymectomy is shown to be effective in preventing
the development of DMBA-induced leukaemia in Swiss mice. The present report
concerns unilateral development of ovarian tumours in the thymectomized Swiss
mice that received a single injection ofDMBA, in a small dose, at neonatal age.
EXPERIMENTAL PROCEDURES
Female Swiss mice, raised in our laboratory, were used in the present experi-
ment. They were given one subcutaneous injection, at the interscapular region,
of 60 fig. of DMBA, suspended in 1P0 per cent aqueous gelatine solution, at birth
(within 24 hours after birth). Mice of Group I were kept without any further
treatment. Neonatally DMBA-treated mice of Group II received thymectomy
at 35 ± 5 days of age under the technique previously described (Nakakuki and
Nishizuka, 1964) to prevent leukaemia development. Mice of Group III were
given DMBA injection at birth, then thymectomized at 35 + 5 days of age and
grafted subcutaneously either with 1-day-old homologous (Swiss) thymuses or
with autologous thymuses; each animal received one whole thymus. The thymus
grafts were placed into the inguinal fat pads of the right side immediately after
thymectomy. Many grafts were recovered when the mice were killed.
Female Swiss mice without any treatment and mice thymectomized at 35 ± 5
days with or without grafting of 1-day-old whole thymus of Swiss mice served as
controls.DMBA OVARIAN TUMOURS IN MICE
The mice were kept in metal boxes, 5-6 per box, and were fed on a commercial
diet in pellet form. They were inspected twice a week for leukaemia and other
tumours and were killed when leukaemia became evident or palpable tumours
became large or they were otherwise in poor condition. At autopsy, solid
ovarian tumours or cysts, and the uterus as well, were removed, weighed on a
torsion balance and examined histologically. Leukaemic tissues, lung, kidney,
liver, uteri, and ovaries with normal appearance were also removed for histo-
logical study. Most of the animals that reached 34 weeks of age were killed since
they were usually in poor conditions due to the development of multiple lung
adenomatosis, and only a few animals were allowed to live until they reached 52
weeks of age.
EXPERIMENTAL FINDINGS
As shown in Tables I and II, control Swiss mice without DMBA treatment had
low incidence of leukaemia and ovarian tumour. DMBA treatment at neonatal
stage yielded a high incidence of thymic leukaemia. Thymectomy performed at
35 days of age resulted in a marked reduction in leukaemic incidence of the Swiss
mice neonatally injected with DMBA. The grafting ofthymic tissue, homologous
and autologous, did not restore leukaemia development in the present experi-
mental system. The survival of mice of the three experimental groups, non-
thymectomized, thymectomized, and thymectomized followed by thymus
grafting, was in general determined by the rate of appearance of leukaemia.
Animals killed orthat died after 15weeks ofage always had multiple lung adenomas
of varying numbers and sizes. Table I gives incidence of leukaemias and other
tumours in all the groups, and Table II, the incidence of ovarian tumours.
Leukaemia.-Thymic leukaemia developed in 46 out of the 54 mice (88.9 per
cent) in Group I. Deaths from leukaemia commenced at 8 weeks of age and the
majority of leukaemic mice died at less than 26 weeks of age. In contrast, the
incidence ofleukaemia in both Groups II and III fell into a range of 27-29 per cent,
and about half of leukaemic cases died at the ages over 26 weeks after DMBA
injection. The details ofleukaemogenesis in thymectomized mice will be described
elsewhere.
Ovarian Tumour. Only 3 of the total of 54 females of Group I developed
ovarian tumours, the incidence being only 5'6 per cent with a mean latency of 29
weeks. In Groups II and III, where leukaemia development was markedly
inhibited by thymectomy, the incidence of ovarian tumours increased and was
31-2 per cent and 28'6 per cent, respectively. Of the total of 83 thymectomized
mice, macroscopic tumours were present in 23 animals. In 2 mice, tumours
were suspected macroscopically because ofinequality in size ofthe ovaries, though
the larger ovary did not exceed 30 mg. in weight. Inequality in size of the
ovaries was occasionally observed and some of the larger ovaries contained
proliferative foci composed of darker cells probably showing pseudofollicular
differentiation. However, because accurate recognition of an early tumour
offered difficulties, diagnosis of tumour was mostly based upon the size ofenlarged
ovary. Ovaries less than 20 mg. irrespective ofthe presence ofhistologic patterns
suggestive ofneoplastic growth has been excluded from the data in Table II. The
earliest ovarian tumour was found in a thymectomized mouse of 17 weeks of age.
The mean latent period ofthe tumour development was almost the same in the two
thymectomized groups.
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TABLE III.-Weights of Ovarian Tumours
Weights of Weights of No. of
ovarian tumours contralateral ovaries cases
(g.) (g.)
>1-0 . <0-01 7
0-99-05 . <0-01 . 4
0-49-0-1 . <0-01 . 10
0-09-0-03 . <0-01 . 4
0-03-0-02 . <0-01 . 2
0 03-0-02 . 0 02-0*01 . 1
Ovarian tumours were usually found in one ovary, no preponderant side being
noticed, however (Table III). The ovary of the opposite side was always small
and atrophic, usually yellow in colour, but occasionally greyish. The tumours
occasionally exceeded 1l5 g. in weight and were generally of a pinkish-grey colour.
When necrosis or haemorrhage was present some were mottled with yellow spots
or dark red. All the tumours found to date were of granulosa cell origin and
characterized by the formation of pseudofollicular structure accompanied by
various variations containing adenomatous, papillary, or cystic areas, and inter-
mingled occasionally with scattered areas of luteinization. No typical luteoma
was found. One tumour that developed in a thymectomized mouse had multiple
metastatic deposits in the liver. Teleangioectasis was found also in the liver of
this case. The absence ofviable follicles and corpora lutea was the most striking
finding noticed in the contralateral ovaries of tumour-bearing mice and in both
ovaries of the tumour-free mice (Fig. 1 and 2).
The uterus was sometimes hypertrophic when an ovarian tumour was present,
but this was not always the case. Twenty-three of the 28 tumour-bearing mice
showed evidence of oestrous or suboestrous activity near the time of death, but
mice without tumours showed no oestrous activity.
Mammary Carcinoma.-Mammary carcinoma was observed in 10 tumour-
bearing mice. However, no difference in mammary carcinoma incidence was
found between mice with and without ovarian tumours.
DISCUSSION
The incidence of ovarian tumour was low in non-thymectomized Swiss mice
following neonatal exposure to DMBA because the majority of the treated mice
died from thymic leukaemia before ovarian tumours became manifest. Ovarian
tumours appeared in a fairly high frequency when the development of thymic
leukaemia wasprotected byremoval ofthe thymus. These experiments showthat
ovarian tumour of granulosa cell origin can be induced by a single subcutaneous
injection of a small dose of DMBA at neonatal stage. This may indicate that
the immature ovary is susceptible to tumorigenic response to DMBA, and further,
that initiation ofovarian tumorigenesis by DMBA takes place shortly after DMBA
EXPLANATION OF PLATE
FIG. 1.-Granulosa cell tumour developed in a Swiss mouse, aged 34 weeks, that was given
60 ug. DMBA at birth and then thymectomized at 35 days of age. H. and E. x 120.
FIG. 2.-Atrophic appearance of the contralateral ovary of the same mouse shown in Fig. 1.
H. and E. x 120.
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exposure, but the tumours appeared late in life probably due to their slow growth
rate. This agrees with the experiment reported by Jull, Streeter and Sutherland
(1966) who have shown that neoplastic transformation of ovarian tissue of adult
age began within 24 hours after DMBA administration. It has been reported
that immunodepression after thymectomy shows an enhancing influence on
chemical carcinogenesis in the skin (Miller, Grant and Roe, 1963; Grant and
Miller, 1965) and in the liver (Nishizuka, Nakakuki and Usui, 1965). It seemed
clearthattheincreased ovariantumourincidence wasnotbased onthismechanism,
since no significant difference in incidence was observed between the group that
received adult thymectomy and the group that received thymectomy followed
by thymus-grafting. Grafting of thymus into thymectomized mice has been
shown to restore deficiency of immunological capacity (Miller, 1962).
Taking into consideration that both ovaries were equally affected by the
carcinogenic chemical given at the neonatal stage, it should be emphasized that
ovarian tumour developed usually in one ovary and the contralateral ovary was
usually atrophic. The unilateral development ofovarian tumour was also noticed
by previous investigators (Howell, Marchant and Orr, 1954; Kuwahara, 1967).
It seemed probable that the presence of ovarian tumour inhibited the subsequent
development of tumour in the ovary of the opposite side. Marchant (1960) has
reported that the presence of grafts of normal ovaries showed an inhibitory effect
on ovarian tumorigenesis in the (C57B1 x IF) ovariectomized mice with unilateral
grafts from mice pretreated with DMBA. Unilateral development ofthe tumour
in these two experiments may be based on the same biological mechanism and it
appears likely that hormone production from the preceeding ovarian tumour,
which is suggested from the morphological changes in the uterus oftumour-bearing
mice, is a possible cause of protection of the development of the second tumour.
Thus, it is considered that a hormone dependent stage may exist in ovarian
tumorigenesis.
SUMMARY
Neonatal injection of 60 ,ug. DMBA in aqueous gelatine induced leukaemias
in 88-9 per cent andovariantumoursin 5-6 percentoffemale Swissmice. Thymec-
tomy at 35 days ofage decreasedleukaemia incidence to 27a1 per cent andincreased
ovarian tumour incidence to 31-2 per cent. Thymus grafts from autologous or
homologous donors to thymectomized mice gave the same results in tumour
development. The ovarian tumours thus induced were unilateral and ofgranulosa
cell origin.
These experiments indicate that immature ovaries are susceptible to carcino-
genic response to DMBA. Further, it is probable that the presence of ovarian
tumour may inhibit the subsequent development of tumour in the ovary of the
opposite side.
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